Phadia US Inc recalls EliA GliadinDP IgG Well in the Phadia 2500EE instrument (Material Number 12410002) EliA GliadinDP IgG is intended for t…
- Recall date
- May 1, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- Z-2040-2023
- FDA classification
- Class II
- Brand / firm
- Phadia US Inc
- Sold / distributed
- US: CA, NJ, MI
Why it was recalled
Higher reported results when running EliA GliadinDP IgG Well on the instruments Phadia 2500EE compared to running EliA GliadinDP IgG Well on Phadia 250 instrument
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
EliA GliadinDP IgG Well in the Phadia 2500EE instrument (Material Number 12410002) EliA GliadinDP IgG is intended for the in vitro semi-quantitative measurement of IgG antibodies directed to gliadin in human serum or plasma (Li-heparin, EDTA) to aid in the diagnosis of celiac disease Material Number 14553901
Get recall alerts
Free email alert whenever Phadia US Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Phadia US Inc